Abstract:IntroductionMesenchymal stem cells (MSCs) have potential for the treatment of myocardial infarction. However, several meta-analyses revealed that the outcome of stem cell transplantation is dissatisfactory. A series of studies demonstrated that the combination of cell and gene therapy was a promising strategy to enhance therapeutic efficiency. The aim of this research is to investigate whether and how the combination of overexpression of hypoxia-inducible factor-1α (HIF-1α) and co-transplantation of mesenchymal stem cells can enhance cardiac repair in myocardial infarction.MethodsWe investigated the therapeutic effects of myocardial transfection of HIF-1α and co-transplantation of MSCs on cardiac repair in myocardial infarction by using myocardial transfection of HIF-1α via an adenoviral vector. Myocardial infarction was produced by coronary ligation in Sprague-Dawley (SD) rats. Animals were divided randomly into six groups: (1) HIF-1α + MSCs group: Ad-HIF-1α (6 × 109 plate forming unit) and MSCs (1 × 106) were intramyocardially injected into the border zone simultaneously; (2) HIF-1α group: Ad-HIF-1α (6 × 109 plate forming unit) was injected into the border zone; (3) HIF-1α-MSCs group: Ad-HIF-1α transfected MSCs (1 × 106) were injected into the border zone; (4) MSCs group: MSCs (1 × 106) were injected into the border zone; (5) Control group: same volume of DMEM was injected; (6) SHAM group. Cardiac performance was then quantified by echocardiography as well as molecular and pathologic analysis of heart samples in the peri-infarcted region and the infarcted region at serial time points. The survival and engraftment of transplanted MSCs were also assessed.ResultsMyocardial transfection of HIF-1α combined with MSC transplantation in the peri-infarcted region improved cardiac function four weeks after myocardial infarction. Significant increases in vascular endothelial growth factor (VEGF) and stromal cell-derived factor-1α (SDF-1α) expression, angiogenesis and MSC engraftment, as well as decreased cardiomyocyte apoptosis in peri-infarcted regions in the hearts of the HIF-1α + MSCs group were detected compared to the MSCs group and Control group.ConclusionsThese findings suggest that myocardial transfection of HIF-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in myocardial infarction, indicating the feasibility and preliminary safety of a combination of myocardial transfection of HIF-1α and MSC transplantation to treat myocardial infarction.

Combination of Igf-1 Gene Manipulation and 5-Aza Treatment Promotes Differentiation of Mesenchymal Stem Cells into Cardiomyocyte-Like Cells

Abstract. Mesenchymal stem cell (MSC) transplantation has been proposed as a promising therapeutic strategy for ischemic myocardium repair following myocardial infarction. Differentiation of MSCs into cardiomyocyte-like cells prior to cell transplantation is advantageous in improving their potential

Effect of Insulin-Like Growth Factor-1 on Mesenchymal Stem Cell Transplantation and Myocardium Rebuilding in Myocardial Infarction Rats

Optimizing Cardiomyocyte Differentiation: Comparative Analysis of Bone Marrow and Adipose-Derived Mesenchymal Stem Cells in Rats Using 5-Azacytidine and Low-Dose FGF and IGF Treatment

Effects of Insulin-Like Growth Factor 1 on the Myocardium Regeneration and Anti-Inflammation in Mesenchymal Stem Cells

Insulin-Like Growth Factor 1 Treatment of MSCs Attenuates Inflammation and Cardiac Dysfunction Following MI

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

e0205 MicroRNA regulation of cardiomyocyte lineages from bone marrowderived mesenchymal stem cells

Fibrin Patch-Based Insulin-Like Growth Factor-1 Gene-Modified Stem Cell Transplantation Repairs Ischemic Myocardium

Bone Marrow Mesenchymal Stem Cells Induce Angiogenesis and Attenuate the Remodeling of Diabetic Cardiomyopathy

Proliferation of MSCs of Mice in Vitro and 5-Azacytidine Induces the Differentiation of MSCs into Cardiomyogenic Cells

IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway

Rat marrow-derived mesenchymal stem cells can be induced into cardiomyocytes in vitro

ISL1 Overexpression Enhances the Survival of Transplanted Human Mesenchymal Stem Cells in a Murine Myocardial Infarction Model.

Cardiomyocyte-like Differentiation of Human Bone Marrow Mesenchymal Stem Cells after Exposure to 5-Azacytidine in Vitro

Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction

An Experimental Study on Cardiomyogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Induced by Astragaloside Combined with 5-Azacytidine

Differentiation of Bone Marrow Mesenchymal Stem Cells to Myotube-like Structure

Differentiation of Cardiomyocytes from Amniotic Fluid-Derived Mesenchymal Stem Cells by Combined Induction with Transforming Growth Factor Β1 and 5-Azacytidine

Experimental Study the Cardiomyogenic Differentiation of Bone Marrow Mesenchymal Stem Cell Induced by 5-Azacytidine in a "Cardiac-Like" Milieu

Transplantation of Angiogenin-Overexpressing Mesenchymal Stem Cells Synergistically Augments Cardiac Function in A Porcine Model of Chronic Ischemia